What we know of Leronlimab is a 24% reduction in critical,
What we know of Leronlimab is a 24% reduction in critical, with no SAEs, and a 6 day reduction in hospital stay. As Doc 500 has said, this would be a perfect use of the EUA. If for some reason, greater numbers of critical patients produce a much different result, the EUA could be withdrawn. FDA does not want to give full approval because explaining that decision if results change would diminish FDA status. (I very much doubt that our results with more patients would be less efficacious but it certainly is what the EUA is for). So all of you longs, with your left hand keep commenting on Investors Hangout but with your right hand, write to every social media forum you can find and make sure the FDA knows we are watching. We know the Leronlimab efficacy on critical patients and we know that EUA is the right decision. Maybe Canada, Brazil or Philippines will act more promptly because they have a different paradigm and do not fear economic sanctions
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Acoustic Insulation Market Growth Prospects by 2028 The global acoustic insulation market is on track for considerable growth, forecasted at an annual increase of 4.3% between 2023 and 2028. By the year's end in 2028, the market size is projected to reach an impressive US$ 15.5 billion, according to recent analysis. Insights from the Comprehensive Stratview Research...
Continue Reading
Leader Harmonious Drive Systems: A Strong Player in Industrial Robotics Recently, JPMorgan resumed its coverage on Leader Harmonious Drive Systems (688017:CH), a distinguished supplier in the industrial robotics space. They assigned a Neutral rating while significantly raising the price target to RMB109.00, a leap from the previously set RMB44.00. Financial Health...
Continue Reading
JPMorgan Embraces Digital Assets for Loans JPMorgan Chase & Co. (NYSE:JPM) is making a groundbreaking move by permitting institutional clients to use Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) as collateral for loans. This significant shift marks a new phase in the relationship between traditional banking and digital currencies. Launch of the Crypto Collateral...
Continue Reading
Aleph Expands Global Reach with Strategic Localpayment Acquisition Aleph, a leader in the digital marketing ecosystem, has recently made a significant move by acquiring a controlling equity interest in Localpayment. This acquisition is strategically aimed at taking advantage of the burgeoning digital payments market, which is projected to reach $1.4 trillion in the near...
Continue Reading
Transforming Team Management with Centrical Centrical has introduced its groundbreaking solution, Team Performance Central, along with its AI Assistant. Designed specifically for frontline team leaders, this platform aims to enhance their efficiency. It streamlines team management by offering a detailed overview of performance metrics and valuable insights, ultimately...
Continue Reading
